(NYSE: STVN) Stevanato Group Spa's forecast annual revenue growth rate of 10.65% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.77%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.23%.
Stevanato Group Spa's revenue in 2024 is $1,179,732,608.On average, 3 Wall Street analysts forecast STVN's revenue for 2024 to be $383,251,294,504, with the lowest STVN revenue forecast at $380,419,134,339, and the highest STVN revenue forecast at $387,580,069,411. On average, 4 Wall Street analysts forecast STVN's revenue for 2025 to be $424,886,088,156, with the lowest STVN revenue forecast at $418,431,493,770, and the highest STVN revenue forecast at $431,585,980,772.
In 2026, STVN is forecast to generate $473,811,263,415 in revenue, with the lowest revenue forecast at $468,732,407,897 and the highest revenue forecast at $478,890,118,934.